223 related articles for article (PubMed ID: 27149487)
1. Clinical Implication of Inflammation-Based Prognostic Score in Pancreatic Cancer: Glasgow Prognostic Score Is the Most Reliable Parameter.
Yamada S; Fujii T; Yabusaki N; Murotani K; Iwata N; Kanda M; Tanaka C; Nakayama G; Sugimoto H; Koike M; Fujiwara M; Kodera Y
Medicine (Baltimore); 2016 May; 95(18):e3582. PubMed ID: 27149487
[TBL] [Abstract][Full Text] [Related]
2. Inflammatory response related scoring systems in assessing the prognosis of patients with pancreatic ductal adenocarcinoma: a systematic review.
Ahmad J; Grimes N; Farid S; Morris-Stiff G
Hepatobiliary Pancreat Dis Int; 2014 Oct; 13(5):474-81. PubMed ID: 25308357
[TBL] [Abstract][Full Text] [Related]
3. The glasgow prognostic score as a predictor of survival in patients with potentially resectable pancreatic adenocarcinoma.
La Torre M; Nigri G; Cavallini M; Mercantini P; Ziparo V; Ramacciato G
Ann Surg Oncol; 2012 Sep; 19(9):2917-23. PubMed ID: 22488099
[TBL] [Abstract][Full Text] [Related]
4. Validation and clinical usefulness of pre- and postoperative systemic inflammatory parameters as prognostic markers in patients with potentially resectable pancreatic cancer.
Hoshimoto S; Hishinuma S; Shirakawa H; Tomikawa M; Ozawa I; Ogata Y
Pancreatology; 2020 Mar; 20(2):239-246. PubMed ID: 31862230
[TBL] [Abstract][Full Text] [Related]
5. Prognostic indicators based on inflammatory and nutritional factors after pancreaticoduodenectomy for pancreatic cancer.
Watanabe J; Otani S; Sakamoto T; Arai Y; Hanaki T; Amisaki M; Tokuyasu N; Honjo S; Ikeguchi M
Surg Today; 2016 Nov; 46(11):1258-67. PubMed ID: 26869184
[TBL] [Abstract][Full Text] [Related]
6. C-Reactive Protein-based Prognostic Measures Are Superior at Predicting Survival Compared with Peripheral Blood Cell Count-based Ones in Patients After Curative Resection for Pancreatic Cancer.
Fujiwara Y; Haruki K; Shiba H; Hamura R; Horiuchi T; Shirai Y; Furukawa K; Gocho T; Yanaga K
Anticancer Res; 2018 Nov; 38(11):6491-6499. PubMed ID: 30396977
[TBL] [Abstract][Full Text] [Related]
7. The value of inflammation based prognostic scores in patients undergoing surgical resection for oesophageal and gastric carcinoma.
Wen J; Bedford M; Begum R; Mitchell H; Hodson J; Whiting J; Griffiths E
J Surg Oncol; 2018 Jun; 117(8):1697-1707. PubMed ID: 29761518
[TBL] [Abstract][Full Text] [Related]
8. Significance of the inflammation-based prognostic score in recurrent pancreatic cancer.
Nakagawa K; Sho M; Akahori T; Nagai M; Nakamura K; Takagi T; Tanaka T; Nishiofuku H; Ohbayashi C; Kichikawa K; Ikeda N
Pancreatology; 2019 Jul; 19(5):722-728. PubMed ID: 31153778
[TBL] [Abstract][Full Text] [Related]
9. Comparison of the prognostic values of various inflammation based factors in patients with pancreatic cancer.
Wang DS; Luo HY; Qiu MZ; Wang ZQ; Zhang DS; Wang FH; Li YH; Xu RH
Med Oncol; 2012 Dec; 29(5):3092-100. PubMed ID: 22476808
[TBL] [Abstract][Full Text] [Related]
10. Prognostic Value of the CRP/Alb Ratio, a Novel Inflammation-Based Score in Pancreatic Cancer.
Liu Z; Jin K; Guo M; Long J; Liu L; Liu C; Xu J; Ni Q; Luo G; Yu X
Ann Surg Oncol; 2017 Feb; 24(2):561-568. PubMed ID: 27650825
[TBL] [Abstract][Full Text] [Related]
11. Comparison of inflammation-based prognostic scores as predictors of survival outcomes in patients with germ cell tumors.
Yoshinaga K; Sadahira T; Maruyama Y; Mitsui Y; Iwata T; Wada K; Araki M; Watanabe T; Nasu Y
Investig Clin Urol; 2021 Jan; 62(1):47-55. PubMed ID: 33314803
[TBL] [Abstract][Full Text] [Related]
12. Prognostic value of systemic inflammation-based markers in advanced pancreatic cancer.
Martin HL; Ohara K; Kiberu A; Van Hagen T; Davidson A; Khattak MA
Intern Med J; 2014 Jul; 44(7):676-82. PubMed ID: 24750233
[TBL] [Abstract][Full Text] [Related]
13. Prognostic Value of Preoperative Nutritional and Immunological Factors in Patients with Pancreatic Ductal Adenocarcinoma.
Abe T; Nakata K; Kibe S; Mori Y; Miyasaka Y; Ohuchida K; Ohtsuka T; Oda Y; Nakamura M
Ann Surg Oncol; 2018 Dec; 25(13):3996-4003. PubMed ID: 30225838
[TBL] [Abstract][Full Text] [Related]
14. Prognostic impact of the high-sensitivity modified Glasgow prognostic score in patients with resectable non-small cell lung cancer.
Osugi J; Muto S; Matsumura Y; Higuchi M; Suzuki H; Gotoh M
J Cancer Res Ther; 2016; 12(2):945-51. PubMed ID: 27461679
[TBL] [Abstract][Full Text] [Related]
15. A Novel Inflammation-Based Stage (I Stage) Predicts Overall Survival of Patients with Nasopharyngeal Carcinoma.
Li JP; Chen SL; Liu XM; He X; Xing S; Liu YJ; Lin YH; Liu WL
Int J Mol Sci; 2016 Nov; 17(11):. PubMed ID: 27854304
[TBL] [Abstract][Full Text] [Related]
16. Comparison of selected inflammation-based prognostic markers in relapsed or refractory metastatic colorectal cancer patients.
Song A; Eo W; Lee S
World J Gastroenterol; 2015 Nov; 21(43):12410-20. PubMed ID: 26604648
[TBL] [Abstract][Full Text] [Related]
17. Neutrophil-lymphocyte ratio, platelet-lymphocyte ratio, neutrophil-platelet score and prognostic nutritional index: do they have prognostic significance in metastatic pancreas cancer?
Dogan M; Algin E; Guven ZT; Baykara M; Kos TF; Bal O; Zengin N
Curr Med Res Opin; 2018 May; 34(5):857-863. PubMed ID: 29161926
[TBL] [Abstract][Full Text] [Related]
18. The prognostic value of the preoperative c-reactive protein/albumin ratio in ovarian cancer.
Liu Y; Chen S; Zheng C; Ding M; Zhang L; Wang L; Xie M; Zhou J
BMC Cancer; 2017 Apr; 17(1):285. PubMed ID: 28431566
[TBL] [Abstract][Full Text] [Related]
19. Preoperative independent prognostic factors in patients with borderline resectable pancreatic ductal adenocarcinoma following curative resection: the neutrophil-lymphocyte and platelet-lymphocyte ratios.
Asari S; Matsumoto I; Toyama H; Shinzeki M; Goto T; Ishida J; Ajiki T; Fukumoto T; Ku Y
Surg Today; 2016 May; 46(5):583-92. PubMed ID: 26108488
[TBL] [Abstract][Full Text] [Related]
20. Comparison of the prognostic value of tumour- and patient-related factors in patients undergoing potentially curative resection of oesophageal cancer.
Dutta S; Crumley AB; Fullarton GM; Horgan PG; McMillan DC
World J Surg; 2011 Aug; 35(8):1861-6. PubMed ID: 21538187
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
